Astera Labs (NASDAQ:ALAB) Hits New 12-Month High – Still a Buy?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $456.76 and last traded at $455.96, with a volume of 6267145 shares trading hands. The stock had previously closed at $391.74.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Analysts raised price targets on Astera Labs, including a Street-high target increase and a Stifel boost, reinforcing confidence that demand tied to AI data-center spending can stay strong through 2028. Article Title
• Positive Sentiment: The stock hit a new all-time high recently, helped by broader strength in chip stocks and renewed investor enthusiasm for semiconductor names tied to AI. Article Title
• Positive Sentiment: Astera Labs also benefited from a sector rally, with chip shares bouncing as semiconductor sentiment improved across the market. Article Title
• Neutral Sentiment: Coverage around the company’s Nasdaq-100 debut and Russell exit was mixed for shareholders, with index inclusion supportive but the Russell removal potentially offsetting some demand from passive funds. Article Title
• Neutral Sentiment: Recent insider-selling discussion appears tied to prearranged 10b5-1 plans, while institutions are still accumulating shares, so the signal is not clearly negative for the stock. Article Title
• Negative Sentiment: After reaching a fresh high, shares pulled back more than the broader market, suggesting some profit-taking and cooling momentum after the recent surge. Article Title

Analyst Ratings Changes

A number of research firms have recently commented on ALAB. Jefferies Financial Group restated a “buy” rating and set a $270.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. Susquehanna upped their target price on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Rothschild & Co Redburn began coverage on Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price target for the company. Barclays raised their price target on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Finally, Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $265.75.

Astera Labs Stock Performance

The company has a market cap of $73.85 billion, a P/E ratio of 291.12, a P/E/G ratio of 5.54 and a beta of 3.64. The business’s 50-day moving average price is $306.18 and its 200 day moving average price is $202.33.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same period in the prior year, the firm earned $0.33 EPS. Astera Labs’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the company’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the transaction, the general counsel owned 103,343 shares in the company, valued at approximately $30,075,913.29. This represents a 0.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 1,968,942 shares of company stock worth $439,344,964. 10.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Reflection Asset Management acquired a new stake in Astera Labs during the fourth quarter worth approximately $25,000. Smartleaf Asset Management LLC grew its position in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the last quarter. Hilltop National Bank grew its position in shares of Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after purchasing an additional 100 shares during the last quarter. Aventura Private Wealth LLC bought a new position in shares of Astera Labs during the fourth quarter worth approximately $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in shares of Astera Labs during the fourth quarter worth approximately $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.